Focusing on customer (payer, provider) and access influencer (pathways groups, medical benefit management organizations, MDx groups / labs, societies / foundations, value-based care decision support groups, and data and technology partners)

• Payer, provider, & access influencer segmentation, prioritization, & in-depth account profiling inclusive of key decision-maker identification and influence mapping
• Engagement strategies / tactics, access support resources, & value story priorities per stakeholder group for addressing over the short, medium, and long term time horizons
• Emerging access influencer (pathways, OBMs, vertically integrated systems, diagnostics groups, data / technology groups, etc.) differentiating strategic partnerships for brands and franchises

Includes services, data, vendor, and coordination needs across the optimal distribution and dispensing model relative to specialized resource needs (open vs. closed), performance level required (number and mix of vendors), business rules and HUB services coordination (mandatory / voluntary, front vs. back end, good vs. negative redundancies), and differentiated customer experience offerings (custom services)

• Differentiating strategic service and data needs prioritization (including FFS offerings of GPOs), analog assessment, and emerging offerings and vendor evaluation
• Strategically-driven model design, model evolution plan, robust vendor inclusion criteria, and RFP scope and process priorities and best practices for execution
• Distribution, dispensing, & data partner performance management as well as QBR data-driven best practices

Patient journey and provider experience-driven support services / programs (PAP, copay assistance, free drug / voucher, bridge, etc.), configuration, call center, data sources / reporting, orientation to reimbursement specialist team, etc.

• Model design for high impact customer support including trade-off analyses of front vs. back end services, mandatory vs. voluntary coordination, business rules, and competitive needs-driven program benchmarking for differentiating non-product assets support infrastructure
• Operational resource optimization, data / reporting approach, and patient and provider organization stratification for mapping support resource to customer
• Emerging technology-driven support partnerships and predictive analytics for more proactive and responsive issue resolution to compliment traditional services

Relative to ongoing management of performance (internal teams, vendors), competitors, and customers, as well as key partnerships across regional access ecosystems to enhance clinical, operational, and economic value perception of our products

• Customer, influencer, and vendor as well as regional / local level geographic targeting, tracking, and prioritization for greater engagement resource impact
• Strategic data alerts to trigger corrective interventions for addressing emerging customer needs and competitive pressures
• Digital health strategies to enhance RWE, evolving product value stories, and cross-functional collaboration (medical-regulatory-commercial) to enhance market access (patient identification, affordability support options, compliance and persistency, etc.)

Relative to payer, provider, and oncology GPO contracting as well as pull-through strategies and stakeholders

• Pricing / contracting benchmarking and analog data analytics to anticipate customer value perception and behavior
• Modeling for contracting target prioritization, performance thresholds, and key terms / structure, and local level pull-through strategies / tactics
• Progressive performance-based contracting approaches, feasible metric identification, and 3rd party resources to support operationalization

Relative to the strategic and tactical levers including clinical standardization, payment reform, quality measures, cost frameworks, and big data

• 3rd party pathways, key account internal protocols / pathways, medical management groups tracking, alerts, and engagement strategies as well as operational approach
• APM and quality measure strategies to enhance value through optimal operationalization of products, supportive resources, and alignment of medical and commercial
• National and state level HC policy tracking, stakeholder comments / initial perspectives of proposals, implications, and strategic contingency planning

Evaluate clinical pathways adoption by payers and providers, implementation sophistication, financial incentives / penalties and brand-specific access risks or opportunities

Features include comprehensive pathways affiliation mapping, oncologist exposure analysis, in-depth product management assessment, and key influencer identification, supported by profiles of pathways organizations, Excel & PowerPoint-based tool data downloads, and monthly "newsletter" e-mail updates of recent pathways events.

Evaluate coverage restrictions down to a specific indication and line of therapy, in addition to regional coverage targets, and competitive access, to determine coverage threats & opportunities for targeted planning

Features include detailed quality of access & utilization management criteria details per indication and line of therapy, payer review timing, regional access target mapping & restrictions, competitive access, and relevant account management insights.

Establish understanding of high-impact key accounts through assessment of indication-specific clinical, operational and economic behavior & trends to optimize targeted engagement strategies and operationalize tactical planning approaches

Features include interactive account-level profiles encompassing staffing & business model details, clinical sophistication & network affiliation, clinical trials participation, provider-driven pathways utilization / pull-through and influential key decision makers, with opportunity to customize based on client-specific needs and intended use cases.

Discover relevant clinical & non-clinical key decision-makers in oncology across specialties, accounts, networks, and geographies, while gaining insight into their broader spheres of influence, to optimize targeted engagement strategies

Features include a comprehensive KDM lookup tool with extensive attribute selection filters (e.g., tumor specialty, geography, account, role), holistic national influence scoring (customizable based on needs, clear methodology / accessible component sub-scores), detailed individual KDM profiles (e.g., internal dept influence, clinical trials leadership), and convenient Excel exports of relevant KDM subsets.

Explore provider channel economics, including reimbursement trends, net cost recovery dynamics, and impact on account behavior to inform channel strategy

Features include longitudinal payer & provider level reimbursement trends for buy & bill products and associated administration services, detailed net cost recovery estimates by channel for product and labor economics, regional reimbursement & net cost recovery dynamics, and exploration of economic sensitivity through market share / net cost recovery correlation analyses.

Evaluate and monitor the landscape of oncology value-based reimbursement models, including provider / payer participants, program structures, implementation requirements, and other value drivers to understand their impact on patient care

Features include participating provider account and payer mapping, potential patient lives exposed, model overview, tumor types managed, and quality measures tracked, etc.

Profile medical benefit manager (oncology, lab, radiopharmaceutical) payer partnerships, & understand the payer and provider market access impact of MBMs on your target brands

Features include, MBM payer adoption tracking and regional coverage maps, service offerings by MBM and ranking of complexity, profiles of MBM management impact on payer restriction and provider burden, MBM influencers and KDM targets, and MBM account profiles and payer plan look-up.

Evaluate analog distribution and dispensing trends to inform model design and channel strategy based on product and indication-specific characteristics

Features include interactive dashboards to visualize model design trends based on custom filters, vendor inclusion in limited distribution networks, model evolution history, and provider procurement preferences.

Visualize & track VA oncology access to support engagement efforts across national and site-level VA stakeholders

Features include VA medical center site mapping, oncology-specific initiatives & pilot, product access management (formulary, pathways) & key influencer mapping.

Be more proactive and responsive to emerging specialty market access needs, optimize targeting and resourcing through the lens of value and quality, and support strategic engagement planning to enhance pull-through. Schedule a demo with our team to learn more about our different solutions.